Chepurnaya AN, Safuanova GS, Nikulicheva VI, Lekhmus TY, Rakhmatullina AR. [Erythrocytoses in patients with dilated and ischemic cardiomyopathy.].
Klin Lab Diagn 2020;
65:222-227. [PMID:
32227727 DOI:
10.18821/0869-2084-2020-65-4-222-227]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2020] [Accepted: 01/15/2020] [Indexed: 01/29/2023]
Abstract
The aim of research was to evaluate the impact of erythrocytoses on processes of cardiovascular system's remodelling in patients with dilated and ishaemic cardiomyopathies. 35 (42,2%) patients with dilated cardiomyopathy (DCMP) with erythrocytoses, 19 (23,5%) without erythrocytosis, 34 (28,4%) patients with ishaemic cardiomyopathy (ICMP) with erythrocytosis and 50 (60,1%) without erythrocytosis were included in the study. It has been established that erythrocytoses don't wield major influence on the heart's haemodynamics, they appear as a consequence of main diseases and not as their reason, which confirms the domination of congestive heart failure's signs of III-IV stages. In patients with DCMP and ICMP signs of tissue hypoxia were established as well as oxygen reduction in arterial blood to 60,70 ± 1,24 mm Hg in cases of DCMP and 59,60 ± 1,24 mm Hg in cases of ICMP (in verification 75,44 ± 0,93) - p < 0,001. Arguably, erythrocytoses in cases of DCMP and ICMP are a consequence of congestive heart failure, leading to hypoxic erythrocytosis.
Collapse